Search results

  1. ME/CFS Science Blog

    Designing and optimizing clinical trials for long COVID, Vogel et al., 2024

    Does not seem to mention the issue of blinding for non-pharmacological interventions and that in these cases objective outcomes such as actigraphy or employment should be used (alongside symptom questionnaires). I think this is much more important than including under-represented populations or...
  2. ME/CFS Science Blog

    Boom and bust, another ME/CFS myth? - ME/CFS Skeptic blog

    Another paper by Chalder and colleagues compared ME/CFS with rheumatoid arthritis (RA), seronegative spondyloarthropathy (SpA), and connective tissue disease (CTD). The rheumatic diseases had a mean for all or nothing behaviour around 8 and ME/CFS patients a mean around 10, so similar results to...
  3. ME/CFS Science Blog

    Boom and bust, another ME/CFS myth? - ME/CFS Skeptic blog

    For a fair comparison, one should control not only for age and sex but probably also for fatigue (or some other measure of disability).
Back
Top Bottom